Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 98.2 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 117 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 152 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 32.4 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 31.6 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 33.2 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 182 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 142 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 0.0 | BCD100322A01 | 34.2 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 0.5 | BCD100322A03 | 117 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 1.0 | BCD100322A07 | 162 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 2.0 | BCD100322A11 | 188 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 4.0 | BCD100322A15 | 28.4 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 8.0 | BCD100322A19 | 30.9 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 12.0 | BCD100322A23 | 34.4 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 24.0 | BCD100322A27 | 120 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 159 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 217 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 78.7 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 36 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 35 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 128 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 188 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 0.5 | BCD100322A04 | 101 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 1.0 | BCD100322A08 | 185 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 2.0 | BCD100322A12 | 45 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 4.0 | BCD100322A16 | 35.8 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 8.0 | BCD100322A20 | 30.5 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 12.0 | BCD100322A24 | 28.2 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 24.0 | BCD100322A28 | 135 | pmol/sample |